Ackerson BK - Search Results

1

Natural Language Processing for Improved Characterization of COVID-19 Symptoms: Observational Study of 350,000 Patients in a Large Integrated Health Care System.

Malden DE, Tartof SY, Ackerson BK, Hong V, Skarbinski J, Yau V, Qian L, Fischer H, Shaw SF, Caparosa S, Xie F. Malden DE, et al. Among authors: ackerson bk. JMIR Public Health Surveill. 2022 Dec 30;8(12):e41529. doi: 10.2196/41529. JMIR Public Health Surveill. 2022. PMID: 36446133 Free PMC article.

2

Echovirus 11 arthritis in a patient with X-linked agammaglobulinemia.

Ackerson BK, Raghunathan R, Keller MA, Bui RH, Phinney PR, Imagawa DT. Ackerson BK, et al. Pediatr Infect Dis J. 1987 May;6(5):485-8. doi: 10.1097/00006454-198705000-00016. Pediatr Infect Dis J. 1987. PMID: 3601497 No abstract available.

3

The E7 oncoprotein of human papillomavirus type 16 interacts with F-actin in vitro and in vivo.

Rey O, Lee S, Baluda MA, Swee J, Ackerson B, Chiu R, Park NH. Rey O, et al. Virology. 2000 Mar 15;268(2):372-81. doi: 10.1006/viro.1999.0175. Virology. 2000. PMID: 10704345 Free article.

4

Cells with high cyclophilin A content support replication of human immunodeficiency virus type 1 Gag mutants with decreased ability to incorporate cyclophilin A.

Ackerson B, Rey O, Canon J, Krogstad P. Ackerson B, et al. J Virol. 1998 Jan;72(1):303-8. doi: 10.1128/JVI.72.1.303-308.1998. J Virol. 1998. PMID: 9420228 Free PMC article.

5

Human immunodeficiency virus nucleocapsid protein polymorphisms modulate the infectivity of RNA packaging mutants.

Krogstad P, Geng YZ, Rey O, Canon J, Ibarrondo FJ, Ackerson B, Patel J, Aldovini A. Krogstad P, et al. Virology. 2002 Mar 15;294(2):282-8. doi: 10.1006/viro.2001.1319. Virology. 2002. PMID: 12009869 Free article.

6

Cryoelectron microscopic examination of human immunodeficiency virus type 1 virions with mutations in the cyclophilin A binding loop.

Kong LB, An D, Ackerson B, Canon J, Rey O, Chen IS, Krogstad P, Stewart PL. Kong LB, et al. J Virol. 1998 May;72(5):4403-7. doi: 10.1128/JVI.72.5.4403-4407.1998. J Virol. 1998. PMID: 9557731 Free PMC article.

7

Observational safety study of febrile convulsion following first dose MMRV vaccination in a managed care setting.

Jacobsen SJ, Ackerson BK, Sy LS, Tran TN, Jones TL, Yao JF, Xie F, Cheetham TC, Saddier P. Jacobsen SJ, et al. Among authors: ackerson bk. Vaccine. 2009 Jul 23;27(34):4656-61. doi: 10.1016/j.vaccine.2009.05.056. Epub 2009 Jun 9. Vaccine. 2009. PMID: 19520201 Clinical Trial.

8

Safety of Quadrivalent Meningococcal Conjugate Vaccine in 11- to 21-Year-Olds.

Tseng HF, Sy LS, Ackerson BK, Hechter RC, Tartof SY, Haag M, Slezak JM, Luo Y, Fischetti CA, Takhar HS, Miao Y, Cunnington M, Solano Z, Jacobsen SJ. Tseng HF, et al. Among authors: ackerson bk. Pediatrics. 2017 Jan;139(1):e20162084. doi: 10.1542/peds.2016-2084. Pediatrics. 2017. PMID: 28025240

9

Safety of Quadrivalent Meningococcal Conjugate Vaccine in Children 2-10 Years.

Tartof SY, Sy LS, Ackerson BK, Hechter RC, Haag M, Slezak JM, Luo Y, Fischetti CA, Takhar HS, Miao Y, Solano Z, Jacobsen SJ, Tseng HF. Tartof SY, et al. Among authors: ackerson bk. Pediatr Infect Dis J. 2017 Nov;36(11):1087-1092. doi: 10.1097/INF.0000000000001696. Pediatr Infect Dis J. 2017. PMID: 28719502

10

Safety of quadrivalent meningococcal conjugate vaccine in infants and toddlers 2 to 23-months old.

Becerra-Culqui TA, Sy LS, Ackerson BK, Slezak JM, Luo Y, Fischetti CA, Ohadike YU, Curina C, Pellegrini M, Solano Z, Tartof SY, Tseng HF. Becerra-Culqui TA, et al. Among authors: ackerson bk. Vaccine. 2020 Jan 10;38(2):228-234. doi: 10.1016/j.vaccine.2019.10.024. Epub 2019 Oct 21. Vaccine. 2020. PMID: 31648912 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

92 results

Search Page

Filters